ELAREX INC.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- November 1, 2024 – July 31, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q3-1023443
Published purpose
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions